Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants

Author(s):
Zhang, W.; Bailey-Elkin, B.A.; Knaap, R.C.M.; Khare, B.; Dale-Bout, T.J.; Johnson, G.G.; Kasteren, P.B. van; McLeish, N.J.; Gu, J.; He, W.G.; Kikkert, M. (0000-0002-5779-7386); Mark, B.L.; Sidhu, S.S.
Published
2017
Publication type
Article / Letter to editor
MERSCCHFVdeubiquitinasesphage displayubiquitin variantsprotein engineeringinhibitor designantiviral drugs
Date issued
2017-07-31
Language
English
Is part of
Acta Pharmacologica Sinica (2017), Vol. 38, no. 7, p. 1082-1082
hdl
1887/114581